| Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development L Imamovic, MOA Sommer Science translational medicine 5 (204), 204ra132-204ra132, 2013 | 469 | 2013 |
| Bacteriophages carrying antibiotic resistance genes in fecal waste from cattle, pigs, and poultry M Colomer-Lluch, L Imamovic, J Jofre, M Muniesa Antimicrobial agents and Chemotherapy 55 (10), 4908-4911, 2011 | 208 | 2011 |
| Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections L Imamovic, MMH Ellabaan, AMD Machado, L Citterio, T Wulff, S Molin, ... Cell 172 (1), 121-134. e14, 2018 | 167 | 2018 |
| Forecasting the dissemination of antibiotic resistance genes across bacterial genomes MMH Ellabaan, C Munck, A Porse, L Imamovic, MOA Sommer Nature communications 12 (1), 2435, 2021 | 157 | 2021 |
| Predictable modulation of cancer treatment outcomes by the gut microbiota Y Heshiki, R Vazquez-Uribe, J Li, Y Ni, S Quainoo, L Imamovic, J Li, ... Microbiome 8, 1-14, 2020 | 121 | 2020 |
| Characterizing RecA-independent induction of Shiga toxin2-encoding phages by EDTA treatment L Imamovic, M Muniesa PloS one 7 (2), e32393, 2012 | 93 | 2012 |
| Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria B Seelbinder, J Chen, S Brunke, R Vazquez-Uribe, R Santhaman, ... Microbiome 8, 1-20, 2020 | 91 | 2020 |
| Quantification of Shiga toxin-converting bacteriophages in wastewater and in fecal samples by real-time quantitative PCR L Imamovic, E Ballesté, J Jofre, M Muniesa Applied and environmental microbiology 76 (17), 5693-5701, 2010 | 79 | 2010 |
| Phage-mediated Shiga toxin 2 gene transfer in food and water L Imamovic, J Jofre, H Schmidt, R Serra-Moreno, M Muniesa Applied and environmental microbiology 75 (6), 1764-1768, 2009 | 79 | 2009 |
| Mining, analyzing, and integrating viral signals from metagenomic data T Zheng, J Li, Y Ni, K Kang, MA Misiakou, L Imamovic, BKC Chow, ... Microbiome 7, 1-15, 2019 | 74 | 2019 |
| Rapid resistome mapping using nanopore sequencing E van der Helm, L Imamovic, MM Hashim Ellabaan, W van Schaik, A Koza, ... Nucleic acids research 45 (8), e61-e61, 2017 | 71 | 2017 |
| The environmental exposures and inner-and intercity traffic flows of the metro system may contribute to the skin microbiome and resistome K Kang, Y Ni, J Li, L Imamovic, C Sarkar, MD Kobler, Y Heshiki, T Zheng, ... Cell Reports 24 (5), 1190-1202. e5, 2018 | 63 | 2018 |
| Bacteriophages and genetic mobilization in sewage and faecally polluted environments M Muniesa, L Imamovic, J Jofre Microbial biotechnology 4 (6), 725-734, 2011 | 63 | 2011 |
| OI-57, a Genomic Island of Escherichia coli O157, Is Present in Other Seropathotypes of Shiga Toxin-Producing E. coli Associated with Severe Human Disease L Imamovic, R Tozzoli, V Michelacci, F Minelli, ML Marziano, A Caprioli, ... Infection and immunity 78 (11), 4697-4704, 2010 | 50 | 2010 |
| Quantification and evaluation of infectivity of shiga toxin-encoding bacteriophages in beef and salad L Imamovic, M Muniesa Applied and environmental microbiology 77 (10), 3536-3540, 2011 | 43 | 2011 |
| Bluephage: A rapid method for the detection of somatic coliphages used as indicators of fecal pollution in water M Muniesa, E Ballesté, L Imamovic, M Pascual-Benito, D Toribio-Avedillo, ... Water Research 128, 10-19, 2018 | 41 | 2018 |
| Quantification of Shiga toxin 2‐encoding bacteriophages, by real‐time PCR and correlation with phage infectivity L Imamovic, R Serra‐Moreno, J Jofre, M Muniesa Journal of applied microbiology 108 (3), 1105-1114, 2010 | 31 | 2010 |
| Heterogeneity in phage induction enables the survival of the lysogenic population L Imamovic, E Ballesté, A Martínez‐Castillo, C García‐Aljaro, M Muniesa Environmental microbiology 18 (3), 957-969, 2016 | 29 | 2016 |
| Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment K Kang, L Imamovic, MA Misiakou, M Bornakke Sørensen, Y Heshiki, Y Ni, ... Gut microbes 13 (1), 1900995, 2021 | 26 | 2021 |
| Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med 5: 204ra132 L Imamovic, MO Sommer | 21 | 2013 |
